SARS Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
Condition: SARS-CoV-2 Infection Intervention: Biological: B/HPIV3/S-6P Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

SARS-COV-2 Detection From Used Surgical Mask
Condition: SARS-CoV-2 Virus Intervention: Diagnostic Test: SARS-CoV-2 RNA detection Sponsor: Bangkok Metropolitan Administration Medical College and Vajira Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
SINGAPORE and BASEL, Switzerland and SYDNEY, Sept. 5, 2023. ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 5, 2023 Category: Pharmaceuticals Source Type: clinical trials

A Pilot Clinical Evaluation of Astepro ® Nasal Spray for Management of Early SARS-CoV-2 Infection
Condition: COVID-19 Interventions: Drug: Experimental: Primary Cohort; Other: Placebo Comparator: Primary Cohort - Placebo Sponsor: University of Chicago Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials